Discovering The Potential Applications of KRT37: A Protein Involved in Cell Division and Growth

Target Name: KRT37

NCBI ID: G8688

KRT37

Discovering The Potential Applications of KRT37: A Protein Involved in Cell Division and Growth

KRT37 (keratin 37, type I) is a protein that is expressed in a variety of tissues throughout the body, including hair, nails, and skin. It is a key component of the cytoskeleton, which is the structure that gives cells their shape and supports their growth and movement.

Recent studies have suggested that KRT37 may have a number of potential applications as a drug target or biomarker. In this article, we will explore the biology and potential applications of KRT37 in more detail.

The biology of KRT37

KRT37 is a type I transmembrane protein that is expressed in a variety of tissues throughout the body. It is a key component of the cytoskeleton, which is the structure that gives cells their shape and supports their growth and movement. KRT37 is involved in the regulation of cell division and growth, as well as in the development and maintenance of tissues.

One of the defining features of KRT37 is its role in the regulation of cell division. KRT37 is involved in the formation of the mitotic spindle, which is the structure that pulls the chromosomes apart during cell division. In addition, KRT37 is involved in the regulation of the size and shape of cells, which is important for the development and progression of tissues.

In addition to its role in cell division, KRT37 is also involved in the regulation of cell growth and the development of tissues. It is involved in the formation of the extracellular matrix (ECM), which is the structure that surrounds and supports cells. KRT37 is also involved in the regulation of cell migration and the development of tissues, such as skin and hair.

Potential applications of KRT37 as a drug target or biomarker

KRT37 has been suggested as a potential drug target due to its involvement in the regulation of cell division and growth. In addition, KRT37 has also been shown to be involved in the development and progression of certain diseases, which makes it an attractive candidate for use as a biomarker.

One potential application of KRT37 as a drug target is the treatment of cancer. KRT37 has been shown to be involved in the regulation of cell division and growth, which makes it an attractive candidate for the treatment of cancer. For example, studies have shown that inhibiting the activity of KRT37 can lead to the growth arrest and differentiation of certain types of cancer cells. In addition, KRT37 has also been shown to be involved in the development of certain types of cancer, such as breast cancer.

Another potential application of KRT37 as a drug target is the treatment of skin diseases. KRT37 is involved in the regulation of cell division and growth, which makes it an attractive candidate for the treatment of skin diseases. For example, studies have shown that inhibiting the activity of KRT37 can lead to the regression of certain types of skin diseases.

In addition to its potential use as a drug target, KRT37 has also been suggested as a potential biomarker for certain diseases. For example, studies have shown that KRT37 is involved in the regulation of cell division and growth, which makes it an attractive candidate for the diagnosis and prognosis of certain types of cancer. In addition, KRT37 has also been shown to be involved in the development and progression of certain diseases, such as skin disease.

Conclusion

In conclusion, KRT37 is a protein that is expressed in a variety of tissues throughout the body and is involved in the regulation of cell division and growth. Recent studies have suggested that KRT37 may have a number of potential applications as a drug target or biomarker. In addition to its potential use as a drug target, KRT37 has also been shown to be involved in

Protein Name: Keratin 37

The "KRT37 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT37 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets